Head of Endocrinology and Diabetes at Western Health and consultant endocrinologist at The Alfred, Melbourne who specialises in endocrinology & diabetes.
Associate Professor Hamblin is the Program Director of our Endocrinology (Clinical) research program.
The Endocrinology & Diabetes Unit at Western Health provides a broad clinical service covering type 1 and type 2 diabetes, diabetic foot, insulin pumps, continuous glucose monitoring, endocrinology, obstetric endocrinology and metabolic bone. Clinical research areas focus on diabetes, metabolic bone disease and obstetric endocrinology.
Research activities include
- obstetric outcomes in women with type 1 diabetes, type 2 diabetes and gestational diabetes;
- dental health of young adults with diabetes;
- COVID DINGO study: the impact of COVID19 on outcomes in people with diabetes (multi-centre study led by Royal Melbourne Hospital);
- diabetic ketoacidosis associated with SGLT2 inhibitors;
- capillary ketone levels In colonoscopy;
- the role of 4D CT in parathyroid adenoma localisation;
- causes and outcomes of severe inpatient hypernatraemia;
- collaborative research with Prof Gustavo Duque on the effects of parathyroidectomy in frail older persons (Frail-pathy study) and the ORMA study, an evaluation of an IT program to assist GPs diagnose and manage osteoporosis;
- CD-IMPACT study in association with the Department of Nephrology and studies in association with Deakin University: type 1 diabetes attitudes and management in University students;
- usefulness of an app for dietary choices to help people with type 2 diabetes;
- understanding of diabetes medications in the Vietnamese community;
- with Baker Heart Institute, the PREDICT study (a long term observational study of type 2 diabetes) and the NOX1/4 trial in type 1 diabetic nephropathy;
- with the George Institute the FIELD1 study (effect of fenofibrate on retinopathy In type 1 diabetes); and
- with RMIT University the psychological impact of gestational diabetes.